SRS748707 SAMN03198273 539655 human skin metagenome Human microbiome isolated from skin from patient 2 bioproject 267573 PRJNA267573 isolate Patiente 2 age 48 biomaterial_provider swab sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748709 SAMN03198275 539655 human skin metagenome human microbiome from patient 4 bioproject 267573 PRJNA267573 isolate Patiente 4 age 28 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748710 SAMN03198276 539655 human skin metagenome Human microbiome from patient 5 bioproject 267573 PRJNA267573 isolate patient 5 age 28 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748712 SAMN03198314 539655 human skin metagenome Human microbiome from patient 7 bioproject 267573 PRJNA267573 isolate patient 7 age 23 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748713 SAMN03198315 539655 human skin metagenome Human microbiome from patient 8 bioproject 267573 PRJNA267573 isolate Patient 8 age 43 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748716 SAMN03198317 539655 human skin metagenome Human microbiome from patient 9 bioproject 267573 PRJNA267573 isolate patient 10 age 39 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748706 SAMN03198271 539655 human skin metagenome Human microbiome isolated from skin bioproject 267573 PRJNA267573 isolate Patient 1 age 44 biomaterial_provider LIP sex female tissue skin disease Cutaneous Leishmaniasis disease_stage acute population Human sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748708 SAMN03198274 539655 human skin metagenome Human microbiome from patient 3 bioproject 267573 PRJNA267573 isolate Patient 3 age 39 biomaterial_provider LIP sex female tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748711 SAMN03198277 539655 human skin metagenome Human microbiome from patient 6 bioproject 267573 PRJNA267573 isolate patient 6 age 20 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human SRS748715 SAMN03198316 539655 human skin metagenome Human microbiome from patient 9 bioproject 267573 PRJNA267573 isolate patient 9 age 31 biomaterial_provider LIP sex male tissue skin disease Cutaneous Leishmaniasis disease_stage acute sample_type skin sample treatment Gluacantime 20mg/Kg/day during 20days BioSampleModel Human